Toxic clozapine serum levels during inflammatory reactions.
Pfuhlmann
Bruno
B
Hiemke
Christoph
C
Unterecker
Stephan
S
Burger
Rainer
R
Schmidtke
Armin
A
Riederer
Peter
P
Deckert
Jürgen
J
Jabs
Burkhard
B
D014150:Antipsychotic Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D002097:C-Reactive Protein / Q000378:metabolism*; D003024:Clozapine / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism*; D018836:Inflammation Mediators / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015854:Up-Regulation
D014150:Antipsychotic Agents; D018836:Inflammation Mediators; D002097:C-Reactive Protein; D003024:Clozapine